The antisense and RNAi therapeutics market, valued at USD 5.10 Billion in 2024, is growing due to rising genetic research investments and genetic disorder prevalence. Expected to expand at a CAGR of 18.70% during 2025-2034, the market is likely to reach USD 28.32 Billion by 2034, driven by technological advancements in RNA-based treatments. https://www.expertmarketresearch.com/reports/antisense-and-rnai-therapeutics-market